Effective Helicobacter pylori diagnosis could save Germany billions
This article was originally published in Clinica
Executive Summary
If Germany were to introduce specific disease management procedures incorporating better targeted diagnostic and therapy solutions to treat diseases caused by the Helicobacter pylori bacteria, the health service could make savings of between Euro1.8-2bn ($1.8-2bn), says the diagnostic industry trade association, VDGH. This would correspond to the entire amount that the statutory health insurance funds (GKV) currently pay, statutory health insurance physicians for all laboratory tests, it adds.